Insider Selling: Tempus AI, Inc. (NASDAQ:TEM) Major Shareholder Sells 395,800 Shares of Stock

Tempus AI, Inc. (NASDAQ:TEM) major shareholder Bradley A. Keywell sold 395,800 shares of the company’s stock in a transaction that occurred on Wednesday, December 11th. The stock was sold at an average price of $42.95, for a total transaction of $16,999,610.00. Following the sale, the insider now directly owns 16,164,449 shares in the company, valued at $694,263,084.55. This trade represents a 2.39 % decrease in their position. The transaction was disclosed in a document filed with the SEC, which is available through this hyperlink. Major shareholders that own 10% or more of a company’s shares are required to disclose their transactions with the SEC.

Tempus AI Stock Down 2.4 %

TEM stock opened at $41.00 on Friday. The firm’s fifty day simple moving average is $52.64. Tempus AI, Inc. has a 52 week low of $22.89 and a 52 week high of $79.49. The company has a debt-to-equity ratio of 8.17, a quick ratio of 2.55 and a current ratio of 2.69.

Institutional Inflows and Outflows

A number of institutional investors and hedge funds have recently modified their holdings of TEM. NEA Management Company LLC lifted its stake in shares of Tempus AI by 17.8% in the 3rd quarter. NEA Management Company LLC now owns 5,385,979 shares of the company’s stock valued at $304,846,000 after acquiring an additional 813,169 shares during the last quarter. Novo Holdings A S bought a new stake in Tempus AI in the second quarter valued at approximately $142,605,000. Revolution Growth Management Company Inc. purchased a new stake in shares of Tempus AI during the second quarter valued at approximately $128,133,000. ARK Investment Management LLC grew its holdings in shares of Tempus AI by 355.0% in the third quarter. ARK Investment Management LLC now owns 2,378,157 shares of the company’s stock worth $134,604,000 after purchasing an additional 1,855,459 shares during the last quarter. Finally, Alphabet Inc. purchased a new position in shares of Tempus AI in the second quarter worth $54,289,000. 24.22% of the stock is owned by institutional investors.

Analysts Set New Price Targets

A number of research analysts have recently commented on TEM shares. Guggenheim started coverage on shares of Tempus AI in a research report on Monday, December 9th. They set a “buy” rating and a $74.00 price target for the company. Wolfe Research assumed coverage on Tempus AI in a research note on Friday. They issued an “outperform” rating and a $60.00 target price on the stock. Bank of America lifted their price target on Tempus AI from $52.00 to $54.00 and gave the company a “neutral” rating in a research report on Friday. Loop Capital upped their price objective on shares of Tempus AI from $48.00 to $57.00 and gave the stock a “buy” rating in a research report on Tuesday, October 15th. Finally, Stifel Nicolaus downgraded shares of Tempus AI from a “buy” rating to a “hold” rating and raised their target price for the company from $45.00 to $65.00 in a research note on Monday, November 11th. Three equities research analysts have rated the stock with a hold rating and nine have assigned a buy rating to the company’s stock. According to MarketBeat, Tempus AI has an average rating of “Moderate Buy” and an average price target of $56.00.

About Tempus AI

Tempus AI Inc is a technology company advancing precision medicine through the practical application of artificial intelligence principally in healthcare. The company provides AI-enabled precision medicine solutions to physicians to deliver personalized patient care and in parallel facilitates discovery, development and delivery of optimal therapeutics.